2025-10786Rule

Fungal Lung DNA Detectors Classified by FDA for Speed

Published Date: 6/13/2025

Rule

Summary

The FDA is officially putting devices that detect fungal DNA in lung samples into a special safety category called Class II. This means these devices will have clear rules to keep them safe and effective, helping patients get better, faster tests. Companies making these devices should get ready for the new rules, which aim to speed up innovation without extra costs or delays.

Analyzed Economic Effects

3 provisions identified: 2 benefits, 0 costs, 1 mixed.

Device Reclassified to Class II

The FDA is classifying devices that detect and identify fungal nucleic acids directly in respiratory specimens into Class II (special controls). The rule says the special controls that apply to this device type are identified in the order and will be codified into the device's classification.

Codified Safety Controls for Tests

The FDA will identify and codify special controls for fungal nucleic acid tests in respiratory specimens to provide a reasonable assurance of safety and effectiveness. The agency says this action will help enhance patients' access to beneficial innovative devices by reducing regulatory burdens.

Manufacturers Should Prepare for New Rules

The summary of the action advises companies that make these devices to get ready for the new Class II special controls and codified requirements. The FDA says the classification aims to reduce regulatory burdens and thereby enhance access to innovative devices.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
6/13/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in